The "Dehydration Cascade": How GLP-1s May Cause Clots Unlike gastroparesis, which is a direct effect of the drug on the stomach muscles, DVT is often a secondary complication caused by how the drug affects your hydration levels and blood viscosity
It is thought that high-risk variants cause APOL1-mediated kidney disease in a way that is very similar to how it causes cytotoxicity in laboratory animals
(46) comparing T1D patients, who received combined kidney and pancreas transplantation, one group received a pancreatic graft allowing portal delivery of insulin, while the other, a graft with systemic pancreas drainage
Why the dose may change later GLP-1 medicines affect appetite, fullness, and food noise
Sometimes they are more easily felt than seen
These disruptions are expected to drive growth and immense changes in the GLP-1 agonists market